Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent intravenous furosemide in children with nephrotic syndrome edema
IRCT20250131064573N1Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide in nephrosis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Change in body weight, Serum creatinine and 3 more. Started Mar 2025; status: completed.
02
Drugs
furosemide
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT20250131064573N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250131064573N1.